ONCODES.PREC.MED. EO-34 Defensive Interval Ratio
ONCODES.PREC.MED. EO-34 defensive interval ratio. ONCODES.PREC.MED. EO-34 (ZR8) has a Defensive Interval Ratio of 553 days as of December 2024. Defensive assets of €5.46 Million (cash €-, short-term investments €4.84 Million, receivables €624.20K) cover 553 days of daily cash needs of €9.88K/day. See ONCODES.PREC.MED. EO-34 (ZR8) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of ONCODES.PREC.MED. EO-34 (2021–2024)
Defensive interval ratio of ONCODES.PREC.MED. EO-34 from 2021 to 2024. This chart shows how ONCODES.PREC.MED. EO-34's Defensive Interval Ratio has evolved across 4 annual periods from 2021 to 2024. As of December 2024, the ratio stands at 553 days, meaning defensive assets of €5.46 Million can fund 553 days of operations without new revenue. Check ONCODES.PREC.MED. EO-34 (ZR8) asset resilience to evaluate the company's liquid asset resilience ratio.
ONCODES.PREC.MED. EO-34 Defensive Interval Ratio by Year (2021–2024)
ONCODES.PREC.MED. EO-34 defensive interval ratio by year from 2021 to 2024. The table below presents the year-by-year Defensive Interval Ratio for ONCODES.PREC.MED. EO-34 from 2021 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see ONCODES.PREC.MED. EO-34 asset portfolio.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 553 days | €5.46 Million | €9.88K/day | €- | €4.84 Million | ▼ -430 days |
| 2023 | 983 days | €11.08 Million | €11.27K/day | €- | €10.01 Million | ▲ +927 days |
| 2022 | 56 days | €606.50K | €10.86K/day | €- | €125.00K | ▼ -51 days |
| 2021 | 107 days | €354.85K | €3.31K/day | €- | €- | — |